Abbott has obtained FDA authorization for a wearable device that monitors both glucose and ketones. Supported claims confirm the authorization, wearable format, and dual monitoring capability, while claims of diabetes indication, continuous operation, and first-in-world status remain unverified. Coverage draws from two sources with limited ideological range.